3.6 TPD CBG project valuation defence and dilution calculator.
A clean one-page model for a bankable compressed biogas project: 3,600 kg/day CBG capacity, ₹16–18 Cr plant cost excluding land, standard revenue/OPEX assumptions, project-readiness valuation logic, and investor dilution scenarios.
3.6 TPD CBG
3,600 kg/day compressed biogas output assumed for the base case.
₹16–18 Cr
Project cost range excluding land. Default calculator value: ₹16.40 Cr.
Editable
Enter land value separately. Land strengthens asset backing but is not included in plant capex.
Flexible
Use the dilution calculator to test ₹6–7 Cr funding and equity impact.
Financial model
Updated with your 3.6 TPD calculation. Change any input and the revenue, expenses, EMI, DSCR, ROI and payback update instantly.
Editable assumptions
Calculated output
Base model excludes carbon credits, liquid bio-fertilizer upside, subsidy/CFA, and tipping fee unless you enter tipping fee manually. Final figures must be validated by DPR, CA, bank term sheet, feedstock contracts and offtake agreements.
Valuation defence
This section converts the financial model and project readiness into a valuation range. It is designed to help promoters resist unfair strong-arm dilution.
Asset-backed floor
Land + development work + partial project readiness create a floor. This is the minimum defence, not the final valuation.
| Land value | ₹1.65 Cr |
| Development / readiness premium | ₹4.95 Cr |
| Indicative floor | ₹6.60 Cr |
Operating EV method
Post-commissioning enterprise value estimated from EBITDA multiple, discounted by project-readiness score.
| EBITDA multiple | 4.0× |
| Post-commissioning EV + land | ₹23.8 Cr |
| Readiness-adjusted value | ₹18.4 Cr |
₹18–22 Cr pre-money
For ₹6–7 Cr investment, this usually keeps investor dilution around 22–30% depending on the strength of documents and control terms.
| Suggested pre-money | ₹20.0 Cr |
| Investment ask | ₹6.50 Cr |
| Indicative investor stake | 24.5% |
Project valuation calculator
Tick the project milestones already achieved. The calculator assigns a valuation-support premium and readiness score. Use this for other CBG projects also.
Derisking checklist
Checkbox amounts are not accounting values. They are valuation-support weights to communicate how much risk has already been removed before the investor enters.
Dilution calculator
Use this to show exactly how much equity an investor receives at different pre-money valuations, and how much promoter control remains.
Deal inputs
Ownership after investment
Scenario table for ₹6–7 Cr raise
| Pre-money valuation | ₹6 Cr investor stake | ₹6.5 Cr investor stake | ₹7 Cr investor stake | Promoter argument |
|---|
Investor pitch narrative
Use this as the public-facing explanation without naming any private client. Replace XYZ CBG Company with the actual project name only when needed.
Strong promoter-side pitch
XYZ CBG Company is not an idea-stage project. It is an asset-backed renewable-fuel infrastructure project with land, DPR/engineering work, feedstock planning, bankability pathway, and a clear 3.6 TPD operating model. The investment is gap equity to unlock project execution, not seed money for experimentation.
The project has multiple revenue lines: CBG sales, solid organic fertilizer, optional tipping fee, liquid fertilizer and future carbon-credit upside. The base model itself shows attractive EBITDA and DSCR before counting optional upside.
Negotiation rule
Do not negotiate from fear. Negotiate from de-risking. A ₹6–7 Cr investor entering after land, DPR, loan work, feedstock effort and EPC planning should not receive control unless they are also taking control-level risk.
Recommended position: target ₹18–22 Cr pre-money; close around 25–30% dilution for ₹6–7 Cr if the investor is strong. Avoid 40–50% dilution unless the investor brings extraordinary strategic value.
Documents that increase valuation
This webpage is a financial education and project-planning template. It is not an offer of securities, investment advice, guarantee of returns, or legal/tax advice. Validate all assumptions independently before fundraising or publishing investor-facing claims.